Company intelligence / Profile preview

Ataraxis AI

New York, New York, United Statesataraxis.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Ataraxis AI has clinically validated its first product, Ataraxis Breast, the world’s first AI-native prognostic/predictive test for breast cancer. In a landmark study involving over 8,000 patients from multiple countries and institutions, the test demonstrated 30% greater accuracy than standard-of-care genomic assays in predicting recurrence risk. It outperformed existing tests like Oncotype DX and was able to reclassify intermediate-risk patients more accurately into low or high risk groups. The company is preparing for commercial launch in the United States[1][3][4].

Therapeutic areas: Oncology
Modalities: Device (diagnostic test)Artificial intelligence platform (AI foundation model)
Industry: Pathology

Drug pipeline

1 asset

Ataraxis Breast

Commercial

Indications: Breast cancer

Partnerships

None publicly disclosed as of June 2025; notable advisors include leaders from NYU and Meta/Facebook AI Research

Beyond the preview

Go deeper on Ataraxis AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ataraxis AI.

Explore the full profile